News & Perspective

Jan 14, 2011

Jan 14, 2011

Antibodies from H1N1 patients raise hope for more versatile flu vaccines

(CIDRAP News) – A team of US researchers reported this week that a set of antibodies derived from 2009 H1N1 influenza patients showed an ability to react with a number of other flu strains, strengthening hopes that it will eventually be possible to create a broadly protective flu vaccine.

Dec 13, 2010

Dec 13, 2010

Some older asthma patients may need high-dose H1N1 vaccine

(CIDRAP News) – A standard dose of H1N1 influenza vaccine appears to work well in people who have asthma, but older patients with severe asthma may need a higher dose, a government-sponsored trial has shown.

Jun 15, 2010

Jun 15, 2010

2009 pandemic vaccine may fight off 1918 virus

(CIDRAP News) – A team of US researchers reported today that the current pandemic H1N1 influenza vaccine protects mice and may protect humans against the 1918 pandemic virus, a finding that should reduce concern about the potential for an accidental or intentional release of that strain.

Dec 17, 2009

Dec 17, 2009

Vaccine availability opens up as doses approach 100 million

(CIDRAP News) – The nation is reaching a new milestone in its fight against pandemic flu, with the number of vaccine doses expected to reach 100 million by the end of the week and nearly half of states opening up immunization to anyone who wants it, federal officials said today.

Dec 11, 2009

Dec 11, 2009

New vaccine technologies on horizon but face roadblocks

(CIDRAP News) – New ways of producing influenza vaccine that would free the process from long-standing problems are on the horizon, federal officials said today, but they added that scientific and regulatory hurdles will slow the products' movement past licensure and into the market.

Nov 24, 2009

Nov 24, 2009

Novartis unveils US cell-based flu vaccine plant

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

Nov 04, 2009

Nov 04, 2009

CDC says vaccine shortage likely to outlast current H1N1 wave

(CIDRAP News) – The head of the Centers for Disease Control and Prevention (CDC) predicted today that the current wave of H1N1 influenza is likely to begin to wane before the shortage of vaccine for it eases.

Dr. Thomas Frieden made the comment at a wide-ranging US House subcommittee session that aired the reasons for and impact of the vaccine delays and the prospects for avoiding a repeat of the problem. The session was streamed over the Web.

Sep 21, 2009

Sep 21, 2009

Trial predicts 2 H1N1 shots for young kids, 1 for older

(CIDRAP News) – The earliest results from testing of a pandemic H1N1 vaccine in children suggest that older children will get a good immune response with a single dose, but children younger than 10 are likely to need two doses a few weeks apart, federal officials said today.

Sep 11, 2009

Sep 11, 2009

More results point to 1-dose regimen for H1N1 vaccines

(CIDRAP News) – US health officials offered more evidence today that a single dose of pandemic H1N1 influenza vaccines may be enough to protect adults, saying preliminary findings in government-sponsored trials reinforce early results from company trials announced yesterday.

Aug 27, 2009

Aug 27, 2009

Experts field questions about novel flu vaccines for pregnant women

(CIDRAP News) – Federal health officials today hosted a Web telecast to help pregnant women and new mothers prepare for an uptick in novel H1N1 flu infections, a day after a federal judge rejected an advocacy group's request to limit use of the H1N1 vaccine in pregnant women.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»